Milbank represented the owners of Naturwohl Pharma GmbH on the sale of all shares to Perrigo, one of the world’s largest manufacturers of OTC-pharmaceutical products, headquartered in Ireland.

The product portfolio of Naturwohl includes Yokebe, the second largest dietary supplement brand in Germany which offers meal replacement products, e.g.  in a shake or liquid form.

The transaction is still subject to approval by the cartel authorities. The transaction volume is confidential.

A Milbank team headed by Norbert Rieger and Andrea Eggenstein advised the owners of Naturwohl Pharma comprehensively on corporate, competition and tax law in relation to the transaction.

Advisor to the owners of Naturwohl Pharma GmbH: Milbank, Tweed, Hadley & McCloy LLP

Norbert Rieger (Corporate M&A, Munich), Andrea Eggenstein (Corporate/M&A, Frankfurt, joint lead), Matthias Schell (Tax, Munich), Alexander Rinne (Antitrust, Munich), Leopold Riedl (Corporate/M&A, Frankfurt), Nina Hornemann (both Corporate/M&A, Frankfurt), Timo Schwarzwälder (Corporate/M&A, Munich)